Julie L.C. Kan

Arginine-Serine-Rich Domains Bound at Splicing Enhancers Contact the Branchpoint to Promote Prespliceosome Assembly

Haihong Shen, Julie L.C. Kan, Michael R. Green · Molecular Cell · 2004 · 242 citations · Full text

Arginine-serine-rich Domains Bound, Transcriptional Regulation, Enhancers Contact +10

PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity

Jing Yuan, Pramod P. Mehta, Min-Jean Yin et al. · Molecular Cancer Therapeutics · 2011 · 159 citations · Full text

Antitumor Activity, Pten Loss, Cancer Biology +22

Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor

Julie L.C. Kan, M. R. Green · Genes & Development · 1999 · 155 citations · Full text

Recognition of unusual DNA structures by human DNA(cytosine-5)methyltransferase

Steven S. Smith, Julie L.C. Kan, David Baker et al. · Journal of Molecular Biology · 1991 · 100 citations

Chromatin, Dna Sequencing, Dna +10

An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735

Kenneth E. Hook, Scott J. Garza, Maruja E. Lira et al. · Molecular Cancer Therapeutics · 2012 · 96 citations · Full text

Myc Gene Family, Engineering, Molecular Biology +23